Correction to: Search of anti-allodynic compounds from Plantaginis Semen, a crude drug ingredient of Kampo formula 'Goshajinkigan'
Autor: | Miki Maesaka, Yanjing Bai, Tsugunobu Andoh, Yue-Wei Ge, Huanhuan Yu, Zhiyan Hou, Kazufumi Toume, Shiho Hanazawa, Katsuko Komatsu, Mitsuru Kato |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Paclitaxel Kampo Iridoid Glucosides Pharmacology toxicology Semen Crude drug Lactones Mice Ingredient Animals Medicine Iridoids Plantago Traditional medicine Plant Extracts business.industry Correction Peripheral Nervous System Diseases Mice Inbred C57BL Goshajinkigan Hyperalgesia Molecular Medicine Medicine Kampo business Drugs Chinese Herbal |
Zdroj: | Journal of Natural Medicines |
ISSN: | 1861-0293 1340-3443 |
Popis: | Chemotherapy-induced peripheral neuropathy (CIPN) is one of the dose-limiting side effects of cancer chemotherapy. Although the control of CIPN is important, it is difficult to manage with currently available therapeutic drugs. Therefore, there is a need for novel therapeutic agents for treating CIPN. Goshajinkigan (GJG) is a Kampo formula composed of ten crude drugs. While GJG has been used for the treatment of CIPN, the active constituents of GJG and their underlying mechanisms of pharmacological effects are still unknown. Our previous study revealed that repetitive oral administration of the water extract of Plantaginis Semen, a crude drug ingredient of GJG, inhibited the mechanical allodynia induced by an intraperitoneal injection of paclitaxel in mice. To elucidate the active compounds of Plantaginis Semen, activity-guided separation of the water extract of Plantaginis Semen was performed. From the active fraction, four iridoids (1-4) were identified. Repetitive oral administration of aucubin (1) at 100 or 30 mg/kg and 100 mg/kg of the fraction crude 3 [primarily comprised of pedicularis-lactone (3)], showed anti-allodynic activity, suggesting 1 and 3 could be some of the active compounds responsible for the anti-allodynic property of Plantaginis Semen and GJG. Our study establishes that oral administration of 1 has potent anti-allodynic effect in addition to the activity of intraperitoneally administered 1 reported previously. Identification of active anti-allodynic compounds found in Kampo formulations will support the development of novel therapies for the management of CIPN in cancer patients. |
Databáze: | OpenAIRE |
Externí odkaz: |